While the role of APP in s-IBM awaits further analysis of clinical samples, it has been demonstrated that ectopic expression of either APP (either wild-type or Swedish mutant) or Aβ42 is sufficient to induce cell death in skeletal muscle either in vitro [19,20] or in vivo [21-23]. The gene discussed is APP; the disease is inclusion body myositis.